The Psychedelic Five | XandY Analytics
Research report · October 2026

Audience segmentation · US adults

The Psychedelic Five

Americans’ views on psychedelics cluster into five distinct personas. Here we show who they are, and how to communicate effectively with each.

Out of every 100 American adults

Advocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsAdvocates: 17.2% of US adultsConflicted: 11.6% of US adultsConflicted: 11.6% of US adultsConflicted: 11.6% of US adultsConflicted: 11.6% of US adultsConflicted: 11.6% of US adultsConflicted: 11.6% of US adultsConflicted: 11.6% of US adultsConflicted: 11.6% of US adultsConflicted: 11.6% of US adultsConflicted: 11.6% of US adultsConflicted: 11.6% of US adultsConflicted: 11.6% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsCurious: 22.5% of US adultsDisconnected: 12.2% of US adultsDisconnected: 12.2% of US adultsDisconnected: 12.2% of US adultsDisconnected: 12.2% of US adultsDisconnected: 12.2% of US adultsDisconnected: 12.2% of US adultsDisconnected: 12.2% of US adultsDisconnected: 12.2% of US adultsDisconnected: 12.2% of US adultsDisconnected: 12.2% of US adultsDisconnected: 12.2% of US adultsDisconnected: 12.2% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adultsOpposed: 36.5% of US adults
Scroll ↓
01 · Our approach

How the segments are formed

We surveyed a representative sample of 1,525 U.S. adults. A statistical model reveals how their responses to 9 key questions about psychedelics tend to cluster into 5 distinct groups.

9 SURVEY QUESTIONSPATTERN-FINDING MODEL5 AUDIENCES1How familiar are you withthe topic of psychedelics?2How positive or negative areyour feelings toward psychedelics?3To what extent are psychedelicsuseful as a mental health therapy?4To what extent are psychedelicsharmful to mental health?5To what extent are psychedelicsgood for society?6To what extent are psychedelicsresponsible for causing violent crime?7To what extent are psychedelicsuseful for treating addiction?8To what extent are psychedelicsaddictive?9Which of these 8 psychedelicsubstances have you ever tried?Latent Class AnalysisThis analysis explores thedata and creates groups ofpeople whose answers followthe same pattern. Itoptimizes for finding groupsthat have high similaritywithin the group, butmaximum distinctionbetween groups.It is never told what thegroups should be. Itorganically discovers whatthe groups are.Advocates17% of US adultsConflicted12% of US adultsCurious22% of US adultsDisconnected12% of US adultsOpposed36% of US adultsKeep scrolling to take the quiz yourself ↓
9 SURVEY QUESTIONS1How familiar are you with the topic ofpsychedelics?2How positive or negative are your feelingstoward psychedelics?3To what extent are psychedelics useful as amental health therapy?4To what extent are psychedelics harmful tomental health?5To what extent are psychedelics good forsociety?6To what extent are psychedelics responsiblefor causing violent crime?7To what extent are psychedelics useful fortreating addiction?8To what extent are psychedelics addictive?9Which of these 8 psychedelic substances haveyou ever tried?PATTERN-FINDING MODELLatent Class AnalysisThis analysis explores the data and createsgroups of people whose answers follow the samepattern. It optimizes for finding groups thathave high similarity within the group, butmaximum distinction between groups.It is never told what the groups should be. Itorganically discovers what the groups are.5 AUDIENCESAdvocates17% of US adultsConflicted12% of US adultsCurious22% of US adultsDisconnected12% of US adultsOpposed36% of US adultsKeep scrolling to take the quiz yourself ↓
From answers to audiences. Nine questions go into a statistical model that sorts people by the pattern of their answers. Policy and trust questions are held back to test the result. Shares weighted, n = 1,525.
02 · The audiences

Meet the Psychedelic Five

Americans tend to cluster into these five distinct personas. They each have different beliefs, support different policy, trust different sources, and need different types of communication approaches.

The five audiences, by share of US adults

Circles are sized by each audience’s share of the adult population and ordered from the most supportive of psychedelics to the most opposed. Click a circle to jump to its profile.

17%Advocates12%Conflicted22%Curious12%Disconnected36%OpposedMOST SUPPORTIVE OF PSYCHEDELICSMOST OPPOSED TO PSYCHEDELICS MOST SUPPORTIVE17%Advocates17% of US adults · Supportive and experienced12%Conflicted12% of US adults · Knowledgeable but torn22%Curious22% of US adults · Unfamiliar but warm12%Disconnected12% of US adults · Not yet in the conversation36%Opposed36% of US adults · Firmly settled againstMOST OPPOSED
Shares weighted to the US adult population, n = 1,525. Ordering follows each audience’s average benefit-minus-harm rating across three pairs of belief questions.

Supportive and experienced

Advocates

17%of US adults
±2.3 pts

Advocates have strong positive views, often due to firsthand experience, and support sweeping policy reform. Almost all of them (98%) see more benefit than harm in psychedelics, 93% feel positively toward them, and a large majority support policy reform (90% support therapeutic medical use; 83% support decriminalization). They are knowledgeable and experienced: on average they have heard of 5 of the 8 substances we asked about, and most have tried at least 1.

Read the communication strategy →

Knowledgeable but torn

Conflicted

12%of US adults
±2.0 pts

The Conflicted are experienced but remain cautious of potential harms. In this group, 85% are either “very” or “extremely” familiar with psychedelics, and 82% have tried at least 1. But more Conflicted say the harms outweigh the benefits (39%) than say that benefits outweigh the harms (22%). This is a complicated mix of warm sentiment (78% report positive feelings) with cautious concern about potential risks. Strikingly, the belief that psychedelics are responsible for violent crime is just as common in the Conflicted (50%) as it is in the Opposed (51%). This dampens their support for policy reform involving unsupervised use, with only a slim majority supporting decriminalization (54%) and legalization (59%).

Read the communication strategy →

Unfamiliar but warm

Curious

22%of US adults
±2.6 pts

The Curious are mostly unfamiliar with psychedelics but remain open enough to consider potential benefits and policy reform. Almost nobody (5%) in this group says they are “very” or “extremely” familiar with psychedelics and only 33% have tried any, but they still land on some tentatively positive views. Although only 10% of the Curious say psychedelics are good for society, 54% feel the benefits outweigh the harms (compared to only 29% who say the reverse). This creates some openness to specific types of policy reform. There is clear majority support for allowing scientists to study psychedelics (74%) but far less for legalization (44%).

Read the communication strategy →

Not yet in the conversation

Disconnected

12%of US adults
±2.0 pts

The Disconnected are not so much opposed as they are simply absent and unaware. In this group, 66% say they are either “not at all” or “only a little” familiar with psychedelics. Across the questions about policy reform, it is common for them to select “unsure” on several (average = 4.4 of 9) rather than indicate support or opposition. In the concept association question, the most common response to the question “What’s the first thing that comes to mind…” was some variant of “Nothing at all.” Most don’t see harms or benefits as outweighing the other, likely because they lack enough information to even offer a guess.

Read the communication strategy →

Firmly settled against

Opposed

36%of US adults
±3.0 pts

The Opposed feel confident in their resistance—often based on firm beliefs about harms. Coming in as the largest audience (36% of U.S. adults), they exert considerable influence with their skepticism. 79% say psychedelics are harmful to mental health, 74% think they are addictive, and only 1% say they are good for society. While a few (16%) have tried at least 1 psychedelic substance, 100% of respondents in the Opposed group said the harms outweigh the benefits. These beliefs have stark effects on policy support, as 79% oppose legalization and 66% oppose religious and spiritual use. However, 63% do support allowing scientists to study psychedelics, which presents a rare opening.

Read the communication strategy →

The core beliefs of the Psychedelic Five

Hover any bar for the exact figure.

Feel positive aboutpsychedelicssomewhat or extremely positiveAdvocatesAdvocates: 93% (all adults 28%)93%ConflictedConflicted: 78% (all adults 28%)78%CuriousCurious: 11% (all adults 28%)11%DisconnectedDisconnected: 4% (all adults 28%)4%OpposedOpposed: 1% (all adults 28%)1%US 28%Feel negativesomewhat or extremely negativeAdvocatesAdvocates: 1% (all adults 38%)1%ConflictedConflicted: 10% (all adults 38%)10%CuriousCurious: 10% (all adults 38%)10%DisconnectedDisconnected: 28% (all adults 38%)28%OpposedOpposed: 86% (all adults 38%)86%US 38%Are very or extremely familiarwith the topic of psychedelicsAdvocatesAdvocates: 62% (all adults 27%)62%ConflictedConflicted: 85% (all adults 27%)85%CuriousCurious: 5% (all adults 27%)5%DisconnectedDisconnected: 7% (all adults 27%)7%OpposedOpposed: 13% (all adults 27%)13%US 27%Say they have tried oneany of eight psychedelics, everAdvocatesAdvocates: 81% (all adults 39%)81%ConflictedConflicted: 82% (all adults 39%)82%CuriousCurious: 33% (all adults 39%)33%DisconnectedDisconnected: 22% (all adults 39%)22%OpposedOpposed: 16% (all adults 39%)16%US 39%See more benefit than harmaveraged over three comparisonsAdvocatesAdvocates: 98% (all adults 33%)98%ConflictedConflicted: 22% (all adults 33%)22%CuriousCurious: 54% (all adults 33%)54%DisconnectedDisconnected: 12% (all adults 33%)12%OpposedOpposed: 0% (all adults 33%)0%US 33%See more harm than benefitthe same comparison, other wayAdvocatesAdvocates: 0% (all adults 52%)0%ConflictedConflicted: 39% (all adults 52%)39%CuriousCurious: 29% (all adults 52%)29%DisconnectedDisconnected: 36% (all adults 52%)36%OpposedOpposed: 100% (all adults 52%)100%US 52%Think they are useful as amental health therapysay very or extremelyAdvocatesAdvocates: 79% (all adults 28%)79%ConflictedConflicted: 47% (all adults 28%)47%CuriousCurious: 33% (all adults 28%)33%DisconnectedDisconnected: 8% (all adults 28%)8%OpposedOpposed: 2% (all adults 28%)2%US 28%Think they are good for societysay very or extremelyAdvocatesAdvocates: 45% (all adults 16%)45%ConflictedConflicted: 40% (all adults 16%)40%CuriousCurious: 10% (all adults 16%)10%DisconnectedDisconnected: 7% (all adults 16%)7%OpposedOpposed: 1% (all adults 16%)1%US 16%Think they are useful fortreating addictionsay very or extremelyAdvocatesAdvocates: 56% (all adults 21%)56%ConflictedConflicted: 48% (all adults 21%)48%CuriousCurious: 20% (all adults 21%)20%DisconnectedDisconnected: 10% (all adults 21%)10%OpposedOpposed: 1% (all adults 21%)1%US 21%Think they are harmful tomental healthsay very or extremelyAdvocatesAdvocates: 5% (all adults 41%)5%ConflictedConflicted: 59% (all adults 41%)59%CuriousCurious: 11% (all adults 41%)11%DisconnectedDisconnected: 17% (all adults 41%)17%OpposedOpposed: 79% (all adults 41%)79%US 41%Think they are responsiblefor causing violent crimesay very or extremelyAdvocatesAdvocates: 5% (all adults 29%)5%ConflictedConflicted: 50% (all adults 29%)50%CuriousCurious: 10% (all adults 29%)10%DisconnectedDisconnected: 12% (all adults 29%)12%OpposedOpposed: 51% (all adults 29%)51%US 29%Think they are addictivesay very or extremelyAdvocatesAdvocates: 10% (all adults 42%)10%ConflictedConflicted: 51% (all adults 42%)51%CuriousCurious: 23% (all adults 42%)23%DisconnectedDisconnected: 14% (all adults 42%)14%OpposedOpposed: 74% (all adults 42%)74%US 42%
1 of 4Feelings and familiarity

Swipe or use the arrows to see all four groups of beliefs

Feel positive about psychedelicssomewhat or extremely positiveAdvocatesAdvocates: 93% (all adults 28%)93%ConflictedConflicted: 78% (all adults 28%)78%CuriousCurious: 11% (all adults 28%)11%DisconnectedDisconnected: 4% (all adults 28%)4%OpposedOpposed: 1% (all adults 28%)1%US 28%Feel negativesomewhat or extremely negativeAdvocatesAdvocates: 1% (all adults 38%)1%ConflictedConflicted: 10% (all adults 38%)10%CuriousCurious: 10% (all adults 38%)10%DisconnectedDisconnected: 28% (all adults 38%)28%OpposedOpposed: 86% (all adults 38%)86%US 38%Are very or extremely familiarwith the topic of psychedelicsAdvocatesAdvocates: 62% (all adults 27%)62%ConflictedConflicted: 85% (all adults 27%)85%CuriousCurious: 5% (all adults 27%)5%DisconnectedDisconnected: 7% (all adults 27%)7%OpposedOpposed: 13% (all adults 27%)13%US 27%
Say they have tried oneany of eight psychedelics, everAdvocatesAdvocates: 81% (all adults 39%)81%ConflictedConflicted: 82% (all adults 39%)82%CuriousCurious: 33% (all adults 39%)33%DisconnectedDisconnected: 22% (all adults 39%)22%OpposedOpposed: 16% (all adults 39%)16%US 39%See more benefit than harmaveraged over three comparisonsAdvocatesAdvocates: 98% (all adults 33%)98%ConflictedConflicted: 22% (all adults 33%)22%CuriousCurious: 54% (all adults 33%)54%DisconnectedDisconnected: 12% (all adults 33%)12%OpposedOpposed: 0% (all adults 33%)0%US 33%See more harm than benefitthe same comparison, other wayAdvocatesAdvocates: 0% (all adults 52%)0%ConflictedConflicted: 39% (all adults 52%)39%CuriousCurious: 29% (all adults 52%)29%DisconnectedDisconnected: 36% (all adults 52%)36%OpposedOpposed: 100% (all adults 52%)100%US 52%
Think they are useful as a mental healththerapysay very or extremelyAdvocatesAdvocates: 79% (all adults 28%)79%ConflictedConflicted: 47% (all adults 28%)47%CuriousCurious: 33% (all adults 28%)33%DisconnectedDisconnected: 8% (all adults 28%)8%OpposedOpposed: 2% (all adults 28%)2%US 28%Think they are good for societysay very or extremelyAdvocatesAdvocates: 45% (all adults 16%)45%ConflictedConflicted: 40% (all adults 16%)40%CuriousCurious: 10% (all adults 16%)10%DisconnectedDisconnected: 7% (all adults 16%)7%OpposedOpposed: 1% (all adults 16%)1%US 16%Think they are useful for treating addictionsay very or extremelyAdvocatesAdvocates: 56% (all adults 21%)56%ConflictedConflicted: 48% (all adults 21%)48%CuriousCurious: 20% (all adults 21%)20%DisconnectedDisconnected: 10% (all adults 21%)10%OpposedOpposed: 1% (all adults 21%)1%US 21%
Think they are harmful to mental healthsay very or extremelyAdvocatesAdvocates: 5% (all adults 41%)5%ConflictedConflicted: 59% (all adults 41%)59%CuriousCurious: 11% (all adults 41%)11%DisconnectedDisconnected: 17% (all adults 41%)17%OpposedOpposed: 79% (all adults 41%)79%US 41%Think they are responsible for causing violentcrimesay very or extremelyAdvocatesAdvocates: 5% (all adults 29%)5%ConflictedConflicted: 50% (all adults 29%)50%CuriousCurious: 10% (all adults 29%)10%DisconnectedDisconnected: 12% (all adults 29%)12%OpposedOpposed: 51% (all adults 29%)51%US 29%Think they are addictivesay very or extremelyAdvocatesAdvocates: 10% (all adults 42%)10%ConflictedConflicted: 51% (all adults 42%)51%CuriousCurious: 23% (all adults 42%)23%DisconnectedDisconnected: 14% (all adults 42%)14%OpposedOpposed: 74% (all adults 42%)74%US 42%
Feelings: “How positive or negative are your feelings towards psychedelics?” Familiarity: “How familiar are you with the topic of psychedelics?” Tried: reported ever trying any of ayahuasca, DMT, ibogaine, ketamine, LSD, mescaline, MDMA or psilocybin; self-reports in online surveys run high, so compare audiences rather than read these as national usage rates. More benefit than harm: the average of the three benefit-minus-harm pairs is above zero. Belief items (useful as a mental health therapy, good for society, useful for treating addiction, harmful to mental health, responsible for causing violent crime, addictive): “To the best of your knowledge, to what extent are psychedelics…” percent answering very or extremely. Weighted, n = 1,525.
03 · Try it yourself

Which one are you?

These exact 9 questions built the Psychedelic 5. Answer them to find out which group you are most likely to belong to.

Your answers stay on this page. Nothing is sent, stored or tracked.

01In general, how familiar are you with the topic of psychedelics (e.g., LSD, psilocybin mushrooms)?
02In general, how positive or negative are your feelings towards psychedelics?
03–08To the best of your knowledge, to what extent are psychedelics…
Not at allOnly a littleModeratelyVeryExtremely
Addictive
Harmful to people’s mental health
Useful as a mental health therapy
Useful for treating addiction
Good for society
Responsible for causing violent crime
09Which of the following psychedelic substances have you ever tried? Select all that apply.

You are most like

See how to reach this audience
04 · Policy support

Some policies have broad support. Others create division.

As expected, most Advocates support most types of policy reform, and the Opposed often oppose. But the data show that some types of policies create more division between the groups, while other policies are more acceptable across the spectrum.

Use these buttons to switch the chart between the share who support, are unsure about, or oppose each policy.

AdvocatesConflictedCuriousDisconnectedOpposedAll adultsAdvocates: 88% support on: Let scientists study psychedelics88% supportConflicted: 65% support on: Let scientists study psychedelics65% supportCurious: 74% support on: Let scientists study psychedelics74% supportDisconnected: 50% support on: Let scientists study psychedelics50% supportOpposed: 63% support on: Let scientists study psychedelics63% supportAll adults: 69% support on: Let scientists study psychedelics69% supportAdvocates: 90% support on: Therapy in a controlled medical setting90%Conflicted: 63% support on: Therapy in a controlled medical setting63%Curious: 68% support on: Therapy in a controlled medical setting68%Disconnected: 44% support on: Therapy in a controlled medical setting44%Opposed: 38% support on: Therapy in a controlled medical setting38%All adults: 58% support on: Therapy in a controlled medical setting58%Advocates: 87% support on: Psilocybin as a therapy for depression87%Conflicted: 71% support on: Psilocybin as a therapy for depression71%Curious: 65% support on: Psilocybin as a therapy for depression65%Disconnected: 39% support on: Psilocybin as a therapy for depression39%Opposed: 37% support on: Psilocybin as a therapy for depression37%All adults: 56% support on: Psilocybin as a therapy for depression56%Advocates: 84% support on: Access by prescription for medical uses84%Conflicted: 60% support on: Access by prescription for medical uses60%Curious: 67% support on: Access by prescription for medical uses67%Disconnected: 34% support on: Access by prescription for medical uses34%Opposed: 27% support on: Access by prescription for medical uses27%All adults: 50% support on: Access by prescription for medical uses50%Advocates: 82% support on: MDMA as a therapy for PTSD82%Conflicted: 66% support on: MDMA as a therapy for PTSD66%Curious: 54% support on: MDMA as a therapy for PTSD54%Disconnected: 31% support on: MDMA as a therapy for PTSD31%Opposed: 33% support on: MDMA as a therapy for PTSD33%All adults: 50% support on: MDMA as a therapy for PTSD50%Advocates: 83% support on: Remove criminal penalties for personal possession83%Conflicted: 54% support on: Remove criminal penalties for personal possession54%Curious: 45% support on: Remove criminal penalties for personal possession45%Disconnected: 31% support on: Remove criminal penalties for personal possession31%Opposed: 13% support on: Remove criminal penalties for personal possession13%All adults: 39% support on: Remove criminal penalties for personal possession39%Advocates: 81% support on: Allow religious and spiritual use81%Conflicted: 57% support on: Allow religious and spiritual use57%Curious: 46% support on: Allow religious and spiritual use46%Disconnected: 23% support on: Allow religious and spiritual use23%Opposed: 13% support on: Allow religious and spiritual use13%All adults: 38% support on: Allow religious and spiritual use38%Advocates: 74% support on: Legal, regulated use for anyone over 2174%Conflicted: 59% support on: Legal, regulated use for anyone over 2159%Curious: 44% support on: Legal, regulated use for anyone over 2144%Disconnected: 27% support on: Legal, regulated use for anyone over 2127%Opposed: 11% support on: Legal, regulated use for anyone over 2111%All adults: 37% support on: Legal, regulated use for anyone over 2137%Advocates: 51% support on: Let drug companies patent and sell their own versions51%Conflicted: 56% support on: Let drug companies patent and sell their own versions56%Curious: 34% support on: Let drug companies patent and sell their own versions34%Disconnected: 16% support on: Let drug companies patent and sell their own versions16%Opposed: 12% support on: Let drug companies patent and sell their own versions12%All adults: 29% support on: Let drug companies patent and sell their own versions29%Let scientists studypsychedelicsTherapy in a controlledmedical settingPsilocybin as a therapyfor depressionAccess by prescriptionfor medical usesMDMA as a therapy for PTSDRemove criminal penaltiesfor personal possessionAllow religious andspiritual useLegal, regulated use foranyone over 21Let drug companies patentand sell their own versions
Let scientists study psychedelicsAdvocatesAdvocates: 88% support on: Let scientists study psychedelics88% supportConflictedConflicted: 65% support on: Let scientists study psychedelics65%CuriousCurious: 74% support on: Let scientists study psychedelics74%DisconnectedDisconnected: 50% support on: Let scientists study psychedelics50%OpposedOpposed: 63% support on: Let scientists study psychedelics63%All adultsAll adults: 69% support on: Let scientists study psychedelics69%Therapy in a controlled medical settingAdvocatesAdvocates: 90% support on: Therapy in a controlled medical setting90%ConflictedConflicted: 63% support on: Therapy in a controlled medical setting63%CuriousCurious: 68% support on: Therapy in a controlled medical setting68%DisconnectedDisconnected: 44% support on: Therapy in a controlled medical setting44%OpposedOpposed: 38% support on: Therapy in a controlled medical setting38%All adultsAll adults: 58% support on: Therapy in a controlled medical setting58%Psilocybin as a therapy for depressionAdvocatesAdvocates: 87% support on: Psilocybin as a therapy for depression87%ConflictedConflicted: 71% support on: Psilocybin as a therapy for depression71%CuriousCurious: 65% support on: Psilocybin as a therapy for depression65%DisconnectedDisconnected: 39% support on: Psilocybin as a therapy for depression39%OpposedOpposed: 37% support on: Psilocybin as a therapy for depression37%All adultsAll adults: 56% support on: Psilocybin as a therapy for depression56%Access by prescription for medical usesAdvocatesAdvocates: 84% support on: Access by prescription for medical uses84%ConflictedConflicted: 60% support on: Access by prescription for medical uses60%CuriousCurious: 67% support on: Access by prescription for medical uses67%DisconnectedDisconnected: 34% support on: Access by prescription for medical uses34%OpposedOpposed: 27% support on: Access by prescription for medical uses27%All adultsAll adults: 50% support on: Access by prescription for medical uses50%MDMA as a therapy for PTSDAdvocatesAdvocates: 82% support on: MDMA as a therapy for PTSD82%ConflictedConflicted: 66% support on: MDMA as a therapy for PTSD66%CuriousCurious: 54% support on: MDMA as a therapy for PTSD54%DisconnectedDisconnected: 31% support on: MDMA as a therapy for PTSD31%OpposedOpposed: 33% support on: MDMA as a therapy for PTSD33%All adultsAll adults: 50% support on: MDMA as a therapy for PTSD50%Remove criminal penalties for personalpossessionAdvocatesAdvocates: 83% support on: Remove criminal penalties for personal possession83%ConflictedConflicted: 54% support on: Remove criminal penalties for personal possession54%CuriousCurious: 45% support on: Remove criminal penalties for personal possession45%DisconnectedDisconnected: 31% support on: Remove criminal penalties for personal possession31%OpposedOpposed: 13% support on: Remove criminal penalties for personal possession13%All adultsAll adults: 39% support on: Remove criminal penalties for personal possession39%Allow religious and spiritual useAdvocatesAdvocates: 81% support on: Allow religious and spiritual use81%ConflictedConflicted: 57% support on: Allow religious and spiritual use57%CuriousCurious: 46% support on: Allow religious and spiritual use46%DisconnectedDisconnected: 23% support on: Allow religious and spiritual use23%OpposedOpposed: 13% support on: Allow religious and spiritual use13%All adultsAll adults: 38% support on: Allow religious and spiritual use38%Legal, regulated use for anyone over 21AdvocatesAdvocates: 74% support on: Legal, regulated use for anyone over 2174%ConflictedConflicted: 59% support on: Legal, regulated use for anyone over 2159%CuriousCurious: 44% support on: Legal, regulated use for anyone over 2144%DisconnectedDisconnected: 27% support on: Legal, regulated use for anyone over 2127%OpposedOpposed: 11% support on: Legal, regulated use for anyone over 2111%All adultsAll adults: 37% support on: Legal, regulated use for anyone over 2137%Let drug companies patent and sell their ownversionsAdvocatesAdvocates: 51% support on: Let drug companies patent and sell their own versions51%ConflictedConflicted: 56% support on: Let drug companies patent and sell their own versions56%CuriousCurious: 34% support on: Let drug companies patent and sell their own versions34%DisconnectedDisconnected: 16% support on: Let drug companies patent and sell their own versions16%OpposedOpposed: 12% support on: Let drug companies patent and sell their own versions12%All adultsAll adults: 29% support on: Let drug companies patent and sell their own versions29%
“How much do you support or oppose the following policies?” Percent who somewhat or strongly support, answer “unsure,” or somewhat or strongly oppose; the three views are switched with the buttons above, and all three are printed in the PDF. Therapy items for PTSD and depression were asked separately, after a sentence noting that some research suggests each could be effective. Weighted, n = 1,525.
05 · Trusted messengers

Who is trusted for information?

We asked everyone to rate how much they trust each of these entities as a source of information about psychedelics. Across the Psychedelic Five, different types of sources rise to the top.

Use these buttons to switch between the share of each audience that trusts a source and how each audience ranks it against its own average source.

AdvocatesConflictedCuriousDisconnectedOpposed
0%25%50%75%100%← FEWER IN THE AUDIENCE TRUST ITMORE TRUST IT →CLINICAL VOICESScientistsAll US adults: 63% trust scientists for information.Advocates: 78% trust scientists for information.Conflicted: 67% trust scientists for information.Curious: 65% trust scientists for information.Opposed: 61% trust scientists for information.Disconnected: 44% trust scientists for information.Doctors or medical expertsAll US adults: 64% trust doctors or medical experts for information.Advocates: 72% trust doctors or medical experts for information.Curious: 65% trust doctors or medical experts for information.Conflicted: 65% trust doctors or medical experts for information.Opposed: 64% trust doctors or medical experts for information.Disconnected: 45% trust doctors or medical experts for information.Psychiatrists or mental health expertsAll US adults: 59% trust psychiatrists or mental health experts for information.Advocates: 82% trust psychiatrists or mental health experts for information.Curious: 63% trust psychiatrists or mental health experts for information.Conflicted: 61% trust psychiatrists or mental health experts for information.Opposed: 51% trust psychiatrists or mental health experts for information.Disconnected: 42% trust psychiatrists or mental health experts for information.LIVED EXPERIENCEPeople who have had psychedelic therapyAll US adults: 47% trust people who have had psychedelic therapy for information.Advocates: 78% trust people who have had psychedelic therapy for information.Conflicted: 62% trust people who have had psychedelic therapy for information.Curious: 50% trust people who have had psychedelic therapy for information.Disconnected: 35% trust people who have had psychedelic therapy for information.Opposed: 31% trust people who have had psychedelic therapy for information.People who have used psychedelicsAll US adults: 44% trust people who have used psychedelics for information.Advocates: 80% trust people who have used psychedelics for information.Conflicted: 58% trust people who have used psychedelics for information.Curious: 44% trust people who have used psychedelics for information.Disconnected: 30% trust people who have used psychedelics for information.Opposed: 28% trust people who have used psychedelics for information.Indigenous practitionersAll US adults: 43% trust indigenous practitioners for information.Advocates: 79% trust indigenous practitioners for information.Conflicted: 60% trust indigenous practitioners for information.Curious: 51% trust indigenous practitioners for information.Disconnected: 29% trust indigenous practitioners for information.Opposed: 22% trust indigenous practitioners for information.Experienced psychedelic guidesAll US adults: 42% trust experienced psychedelic guides for information.Advocates: 80% trust experienced psychedelic guides for information.Conflicted: 68% trust experienced psychedelic guides for information.Curious: 40% trust experienced psychedelic guides for information.Disconnected: 30% trust experienced psychedelic guides for information.Opposed: 21% trust experienced psychedelic guides for information.PEOPLE CLOSE TO HOMEFamily or close friendsAll US adults: 44% trust family or close friends for information.Advocates: 67% trust family or close friends for information.Conflicted: 61% trust family or close friends for information.Curious: 44% trust family or close friends for information.Disconnected: 38% trust family or close friends for information.Opposed: 31% trust family or close friends for information.Religious or spiritual leadersAll US adults: 27% trust religious or spiritual leaders for information.Conflicted: 50% trust religious or spiritual leaders for information.Advocates: 41% trust religious or spiritual leaders for information.Disconnected: 23% trust religious or spiritual leaders for information.Curious: 20% trust religious or spiritual leaders for information.Opposed: 17% trust religious or spiritual leaders for information.INSTITUTIONSThe FDAAll US adults: 44% trust the FDA for information.Conflicted: 53% trust the FDA for information.Opposed: 45% trust the FDA for information.Advocates: 44% trust the FDA for information.Curious: 42% trust the FDA for information.Disconnected: 34% trust the FDA for information.Law enforcementAll US adults: 35% trust law enforcement for information.Conflicted: 49% trust law enforcement for information.Opposed: 42% trust law enforcement for information.Disconnected: 33% trust law enforcement for information.Curious: 27% trust law enforcement for information.Advocates: 23% trust law enforcement for information.Pharmaceutical companiesAll US adults: 29% trust pharmaceutical companies for information.Conflicted: 52% trust pharmaceutical companies for information.Advocates: 29% trust pharmaceutical companies for information.Curious: 28% trust pharmaceutical companies for information.Opposed: 23% trust pharmaceutical companies for information.Disconnected: 23% trust pharmaceutical companies for information.Politicians or elected officialsAll US adults: 13% trust politicians or elected officials for information.Conflicted: 42% trust politicians or elected officials for information.Advocates: 12% trust politicians or elected officials for information.Curious: 10% trust politicians or elected officials for information.Disconnected: 10% trust politicians or elected officials for information.Opposed: 7% trust politicians or elected officials for information.
← FEWER TRUST ITMORE TRUST IT →0%25%50%75%100%CLINICAL VOICESScientistsAdvocates: 78% trust scientists for information.Conflicted: 67% trust scientists for information.Curious: 65% trust scientists for information.Disconnected: 44% trust scientists for information.Opposed: 61% trust scientists for information.Doctors or medical expertsAdvocates: 72% trust doctors or medical experts for information.Conflicted: 65% trust doctors or medical experts for information.Curious: 65% trust doctors or medical experts for information.Disconnected: 45% trust doctors or medical experts for information.Opposed: 64% trust doctors or medical experts for information.Psychiatrists or mental health expertsAdvocates: 82% trust psychiatrists or mental health experts for information.Conflicted: 61% trust psychiatrists or mental health experts for information.Curious: 63% trust psychiatrists or mental health experts for information.Disconnected: 42% trust psychiatrists or mental health experts for information.Opposed: 51% trust psychiatrists or mental health experts for information.LIVED EXPERIENCEPeople who have had psychedelic therapyAdvocates: 78% trust people who have had psychedelic therapy for information.Conflicted: 62% trust people who have had psychedelic therapy for information.Curious: 50% trust people who have had psychedelic therapy for information.Disconnected: 35% trust people who have had psychedelic therapy for information.Opposed: 31% trust people who have had psychedelic therapy for information.People who have used psychedelicsAdvocates: 80% trust people who have used psychedelics for information.Conflicted: 58% trust people who have used psychedelics for information.Curious: 44% trust people who have used psychedelics for information.Disconnected: 30% trust people who have used psychedelics for information.Opposed: 28% trust people who have used psychedelics for information.Indigenous practitionersAdvocates: 79% trust indigenous practitioners for information.Conflicted: 60% trust indigenous practitioners for information.Curious: 51% trust indigenous practitioners for information.Disconnected: 29% trust indigenous practitioners for information.Opposed: 22% trust indigenous practitioners for information.Experienced psychedelic guidesAdvocates: 80% trust experienced psychedelic guides for information.Conflicted: 68% trust experienced psychedelic guides for information.Curious: 40% trust experienced psychedelic guides for information.Disconnected: 30% trust experienced psychedelic guides for information.Opposed: 21% trust experienced psychedelic guides for information.PEOPLE CLOSE TO HOMEFamily or close friendsAdvocates: 67% trust family or close friends for information.Conflicted: 61% trust family or close friends for information.Curious: 44% trust family or close friends for information.Disconnected: 38% trust family or close friends for information.Opposed: 31% trust family or close friends for information.Religious or spiritual leadersAdvocates: 41% trust religious or spiritual leaders for information.Conflicted: 50% trust religious or spiritual leaders for information.Curious: 20% trust religious or spiritual leaders for information.Disconnected: 23% trust religious or spiritual leaders for information.Opposed: 17% trust religious or spiritual leaders for information.INSTITUTIONSThe FDAAdvocates: 44% trust the FDA for information.Conflicted: 53% trust the FDA for information.Curious: 42% trust the FDA for information.Disconnected: 34% trust the FDA for information.Opposed: 45% trust the FDA for information.Law enforcementAdvocates: 23% trust law enforcement for information.Conflicted: 49% trust law enforcement for information.Curious: 27% trust law enforcement for information.Disconnected: 33% trust law enforcement for information.Opposed: 42% trust law enforcement for information.Pharmaceutical companiesAdvocates: 29% trust pharmaceutical companies for information.Conflicted: 52% trust pharmaceutical companies for information.Curious: 28% trust pharmaceutical companies for information.Disconnected: 23% trust pharmaceutical companies for information.Opposed: 23% trust pharmaceutical companies for information.Politicians or elected officialsAdvocates: 12% trust politicians or elected officials for information.Conflicted: 42% trust politicians or elected officials for information.Curious: 10% trust politicians or elected officials for information.Disconnected: 10% trust politicians or elected officials for information.Opposed: 7% trust politicians or elected officials for information.
“How much do you trust or distrust the following as a source of information about psychedelics?” Percent view: the share of each audience that somewhat or strongly trusts the source, with the dashed mark showing all US adults; use this to compare reach, and the relative view to compare priority. Relative view: trust in each source minus that person’s average trust across all thirteen sources, averaged within each audience, in points on the five-point trust scale; right of zero means trusted more than that audience’s average source. This removes the fact that some audiences trust everything more than others do. The grey bar spans the five audiences. Weighted, n = 1,525.

3 Takeaways about Sources of Information

Doctors, scientists and psychiatrists are trusted everywhere.

Across the Psychedelic Five, the highest levels of trust are given to doctors, scientists, and psychiatrists. Among the Curious and the Opposed, there is a substantial drop in trust when moving from these three clinical voices to any other source of information. As a default, this is the best group of messengers to start with for any audience—and then others that fit the particular audience can be layered as complements.

Politicians rank last with everyone.

Every audience—from Advocates to Opposed—places the lowest trust in politicians and elected officials. Even among the Disconnected, who know little about this issue, only 10% say they would trust politicians for information. However, the FDA has substantially higher trust—although still not strong. This suggests that when government officials also inhabit a more trusted identity (scientist; doctor), their trustworthiness increases. Otherwise, though, they should be avoided as sources of information to the public.

Lived-experience voices are trusted by some; distrusted by others.

People who have used psychedelics, experienced guides and Indigenous practitioners sit near the top for Advocates, but fall below average for the Opposed and Disconnected. This means that these messengers should be used selectively to some audiences, not universally to all, to avoid repelling an audience that doesn’t yet value this type of expertise.

06 · Communication strategy

How to talk to each audience

Combining our data with decades of scientific research in the fields of communication strategy and social psychology, here are recommendations for how to be most effective when speaking to each of these audiences.

MOBILIZEAdvocatesLead strong support intoaction.Advocates: 17% of US adultsConflicted: 12% of US adultsCurious: 22% of US adultsDisconnected: 12% of US adultsOpposed: 36% of US adults17%of U.S. adultsWHYAdvocates are already persuaded. What they need mostis a way to get involved, make a difference, and helpothers.LEAD WITHGive them something to do. Provide them withsomething they can pass along – a story, some data,some inspiration – and show them concrete steps forgetting involved. Create a clear pathway to action,whether it’s support, outreach, collaboration, or voting.Frame the cause around healing, policy reform, andaccess for others, as these are all things they tend toalready support.MESSENGERSThis group truly appreciates lived experience, such asexperienced guides, Indigenous practitioners, and thosewith their own stories of healing. Like other groups, theAdvocates do respond well to the clinical voices too, butkeep in mind that the goal here is usually not tore-establish basic facts but rather to find messengersthat inspire and motivate.AVOIDMany advocates are quite skeptical of voices fromindustry and government due to a perception of conflictof interest and misaligned motives. When there is limitedtime or space to interact, do not waste it on persuadingthem of things they already agree with, unless it isintended as a resource for them to use incommunicating with non-Advocates.
MOBILIZEAdvocatesLead strong support into action.WHYAdvocates are already persuaded. What they need mostis a way to get involved, make a difference, and helpothers.LEAD WITHGive them something to do. Provide them withsomething they can pass along – a story, some data,some inspiration – and show them concrete steps forgetting involved. Create a clear pathway to action,whether it’s support, outreach, collaboration, or voting.Frame the cause around healing, policy reform, andaccess for others, as these are all things they tend toalready support.MESSENGERSThis group truly appreciates lived experience, such asexperienced guides, Indigenous practitioners, and thosewith their own stories of healing. Like other groups, theAdvocates do respond well to the clinical voices too, butkeep in mind that the goal here is usually not tore-establish basic facts but rather to find messengersthat inspire and motivate.AVOIDMany advocates are quite skeptical of voices fromindustry and government due to a perception of conflictof interest and misaligned motives. When there islimited time or space to interact, do not waste it onpersuading them of things they already agree with,unless it is intended as a resource for them to use incommunicating with non-Advocates.
REASSUREConflictedResolve the conflict withevidence, not one-sidedexuberance.Advocates: 17% of US adultsConflicted: 12% of US adultsCurious: 22% of US adultsDisconnected: 12% of US adultsOpposed: 36% of US adults12%of U.S. adultsWHYThe Conflicted have seen the pros and cons, and are stillwary of significant harms. They need their concerns tobe taken seriously. Simply exclaiming that psychedelicsare wonderful sounds to them like you have only seenhalf of the picture.LEAD WITHTake the risks seriously in the first sentence byacknowledging the need for guidance, training,responsibility, and safety. Then show the guardrails yousupport: screening, dosing, trained supervision, qualitycontrol, set and setting. Follow with evidence aboutsafety and widespread benefits outweighing rare harms.“Done right” is the key to accessing their support.MESSENGERSA trio of expert voices top their list of trusted sources:doctors, experienced guides, and scientists. What thesethree have in common is that they each know what doingit right looks like. Interestingly, the Conflicted are theaudience that is most trusting of pharmaceuticalcompanies, likely because this entity is associated withcareful testing, quality control, risk mitigation, andempirical evidence—all admirable qualities in the mind ofthe Conflicted.AVOIDAttitudes like “psychedelic exceptionalism” andone-sided exuberance will immediately raise red flags,despite any good intentions. Paradoxically, the mostpassionate and experienced psychedelic leaderssometimes have the most trouble becoming fluent in thelanguage that the Conflicted need to hear.
REASSUREConflictedResolve the conflict with evidence, notone-sided exuberance.WHYThe Conflicted have seen the pros and cons, and are stillwary of significant harms. They need their concerns tobe taken seriously. Simply exclaiming that psychedelicsare wonderful sounds to them like you have only seenhalf of the picture.LEAD WITHTake the risks seriously in the first sentence byacknowledging the need for guidance, training,responsibility, and safety. Then show the guardrails yousupport: screening, dosing, trained supervision, qualitycontrol, set and setting. Follow with evidence aboutsafety and widespread benefits outweighing rare harms.“Done right” is the key to accessing their support.MESSENGERSA trio of expert voices top their list of trusted sources:doctors, experienced guides, and scientists. What thesethree have in common is that they each know whatdoing it right looks like. Interestingly, the Conflicted arethe audience that is most trusting of pharmaceuticalcompanies, likely because this entity is associated withcareful testing, quality control, risk mitigation, andempirical evidence—all admirable qualities in the mindof the Conflicted.AVOIDAttitudes like “psychedelic exceptionalism” andone-sided exuberance will immediately raise red flags,despite any good intentions. Paradoxically, the mostpassionate and experienced psychedelic leaderssometimes have the most trouble becoming fluent in thelanguage that the Conflicted need to hear.
CONVERTCuriousTurn warm openness intofirm support.Advocates: 17% of US adultsConflicted: 12% of US adultsCurious: 22% of US adultsDisconnected: 12% of US adultsOpposed: 36% of US adults22%of U.S. adultsWHYThis is the biggest movable audience, and they have theshortest distance to travel. A majority already estimatethe benefits to outweigh the harms, and two in three(68%) back therapy in a medical setting. But theirpositive leaning is lacking a firm foundation ofknowledge and experience. The goal is to give them that.LEAD WITHAttach substance to their positive feelings. Concreteclinical cases, real patients, personal healing stories,policy successes, and the specific ways that specificgroups can benefit. The Curious do not need to beargued with, because the barrier isn’t some objectionthey hold. Their intuition has already been nudging themtoward support—they just need to gain knowledge andconfidence to convert that intuition into the firm beliefsthat characterize an Advocate.MESSENGERSThe Curious trust the same sources that they would trustfor other advice and information about health andhealing: scientists, doctors, and mental healthprofessionals. While it’s best to lead with these trustedentities, the Curious also indicate some openness totrusting people who have had psychedelic therapy andIndigenous practitioners. This openness stems from anoverall attitude that is typical of the Curious that says “Imyself don’t know much about this, but it seems likeperhaps something good might be happening in somecases.”AVOIDThe tentative support of the Curious likely stems fromvague ideas about the possibility of some benefits undercertain conditions for certain groups. When support isconditional (rather than unconditional), it is quitevulnerable to the wrong policy framing. For example,while the Curious have majority support for allowingmedical therapy (68%), this drops dramatically for legaladult use (44%). So don’t force them into a choicebetween either full legalization or nothing, or they couldtip the wrong way.
CONVERTCuriousTurn warm openness into firm support.WHYThis is the biggest movable audience, and they have theshortest distance to travel. A majority already estimatethe benefits to outweigh the harms, and two in three(68%) back therapy in a medical setting. But theirpositive leaning is lacking a firm foundation ofknowledge and experience. The goal is to give themthat.LEAD WITHAttach substance to their positive feelings. Concreteclinical cases, real patients, personal healing stories,policy successes, and the specific ways that specificgroups can benefit. The Curious do not need to beargued with, because the barrier isn’t some objectionthey hold. Their intuition has already been nudging themtoward support—they just need to gain knowledge andconfidence to convert that intuition into the firm beliefsthat characterize an Advocate.MESSENGERSThe Curious trust the same sources that they wouldtrust for other advice and information about health andhealing: scientists, doctors, and mental healthprofessionals. While it’s best to lead with these trustedentities, the Curious also indicate some openness totrusting people who have had psychedelic therapy andIndigenous practitioners. This openness stems from anoverall attitude that is typical of the Curious that says “Imyself don’t know much about this, but it seems likeperhaps something good might be happening in somecases.”AVOIDThe tentative support of the Curious likely stems fromvague ideas about the possibility of some benefits undercertain conditions for certain groups. When support isconditional (rather than unconditional), it is quitevulnerable to the wrong policy framing. For example,while the Curious have majority support for allowingmedical therapy (68%), this drops dramatically for legaladult use (44%). So don’t force them into a choicebetween either full legalization or nothing, or they couldtip the wrong way.
REACHDisconnectedOffer a simple, friendlyintroduction.Advocates: 17% of US adultsConflicted: 12% of US adultsCurious: 22% of US adultsDisconnected: 12% of US adultsOpposed: 36% of US adults12%of U.S. adultsWHYThe Disconnected are simply ignorant of the entire issue.They are not arguing for or against—they simply don’tknow enough to have an opinion yet. They are a blankslate that needs a very simple, accessible introductionthat steers clear of jargon and counterproductivestereotypes. The goal isn’t to suddenly transform theminto Advocates—it’s just to give them what they need tobecome a little more Curious.LEAD WITHOne simple idea, in plain words: “Doctors and scientistshave been finding that supervised use of psychedelics canhelp treat depression and PTSD. I’ve known people whohave really benefited, too!” They might go all year onlyhearing this 1 piece of information about this topic. Justplant a seed that can grow.MESSENGERSThe data show the Disconnected trust doctors,scientists, and mental health experts the most—but eventhey are not trusted very strongly. This might be due to aperceived lack of relevance (“why would scientists haveanything to say about this?”). Improving their basicknowledge with the simple message above will haveadded benefits of improving their trust in these crediblesources.AVOIDSteer clear of policy details, spirituality, and technicaldata. These angles tend to either be hard to accept onface value with zero prior context, or they involve ideasthat are too complex to fully take root and becomeself-sustained beliefs. Also, don’t assume priorknowledge—as even the word “psychedelics” may needto be defined or clarified.
REACHDisconnectedOffer a simple, friendly introduction.WHYThe Disconnected are simply ignorant of the entireissue. They are not arguing for or against—they simplydon’t know enough to have an opinion yet. They are ablank slate that needs a very simple, accessibleintroduction that steers clear of jargon andcounterproductive stereotypes. The goal isn’t tosuddenly transform them into Advocates—it’s just togive them what they need to become a little moreCurious.LEAD WITHOne simple idea, in plain words: “Doctors and scientistshave been finding that supervised use of psychedelics canhelp treat depression and PTSD. I’ve known people whohave really benefited, too!” They might go all year onlyhearing this 1 piece of information about this topic. Justplant a seed that can grow.MESSENGERSThe data show the Disconnected trust doctors,scientists, and mental health experts the most—but eventhey are not trusted very strongly. This might be due to aperceived lack of relevance (“why would scientists haveanything to say about this?”). Improving their basicknowledge with the simple message above will haveadded benefits of improving their trust in these crediblesources.AVOIDSteer clear of policy details, spirituality, and technicaldata. These angles tend to either be hard to accept onface value with zero prior context, or they involve ideasthat are too complex to fully take root and becomeself-sustained beliefs. Also, don’t assume priorknowledge—as even the word “psychedelics” may needto be defined or clarified.
BRIDGEOpposedBuild rapport and offerreasoning they mighttrust.Advocates: 17% of US adultsConflicted: 12% of US adultsCurious: 22% of US adultsDisconnected: 12% of US adultsOpposed: 36% of US adults36%of U.S. adultsWHYConverting the Opposed to Advocates is not a realisticgoal. Nearly all have very strong negative beliefs rootedin layers of harmful stereotypes and clashingworldviews. The goal is to take it slow, build trust, and letyour warm relationship thaw some of the ice slowly overtime.LEAD WITHFocus on shared values such as mental health, safety,and personal freedom. A helpful open door may be totalk about studying psychedelics, rather than usingthem—as a majority of the Opposed (63%) alreadysupport allowing scientific research. If the opportunitypresents, share information about public access byframing it in rigor: clinical trials, medical supervision,safety data, FDA oversight.MESSENGERSDoctors, scientists, and mental health experts are trustedby a majority of the Opposed. The FDA and lawenforcement fall close behind. This is likely because theOpposed tend to trust sources they think are likely tostart with a default position against psychedelics (likethem) and wouldn’t be speaking with a bias in favor ofthem. This aversion to favorable bias is also why thelived experience sources are trusted by so few of theOpposed.AVOIDDon’t bring unreasonable expectations for change. Anddon’t burn the bridges. We need more interaction withthis group, not less. The only true loss here is if bypushing too hard, you polarize them even further and ruinyour rapport. When choosing sources of information,keep in mind that insiders like experienced guides andIndigenous practitioners are viewed with the mostskepticism by the Opposed. Like with the Disconnected,avoid the insider jargon and difficult concepts.
BRIDGEOpposedBuild rapport and offer reasoning they mighttrust.WHYConverting the Opposed to Advocates is not a realisticgoal. Nearly all have very strong negative beliefs rootedin layers of harmful stereotypes and clashingworldviews. The goal is to take it slow, build trust, andlet your warm relationship thaw some of the ice slowlyover time.LEAD WITHFocus on shared values such as mental health, safety,and personal freedom. A helpful open door may be totalk about studying psychedelics, rather than usingthem—as a majority of the Opposed (63%) alreadysupport allowing scientific research. If the opportunitypresents, share information about public access byframing it in rigor: clinical trials, medical supervision,safety data, FDA oversight.MESSENGERSDoctors, scientists, and mental health experts aretrusted by a majority of the Opposed. The FDA and lawenforcement fall close behind. This is likely because theOpposed tend to trust sources they think are likely tostart with a default position against psychedelics (likethem) and wouldn’t be speaking with a bias in favor ofthem. This aversion to favorable bias is also why thelived experience sources are trusted by so few of theOpposed.AVOIDDon’t bring unreasonable expectations for change. Anddon’t burn the bridges. We need more interaction withthis group, not less. The only true loss here is if bypushing too hard, you polarize them even further andruin your rapport. When choosing sources ofinformation, keep in mind that insiders like experiencedguides and Indigenous practitioners are viewed with themost skepticism by the Opposed. Like with theDisconnected, avoid the insider jargon and difficultconcepts.
07 · What’s next

What we’re building next

We plan to keep collecting data on The Psychedelic Five, and keep building free resources that can be helpful to the whole community.

Winter 2026–27

A second wave of data

We will be fielding a new wave of survey data this winter. It will show how The Psychedelic Five have changed over time, and where they are headed in the future. We aim to present the updated findings at Psychedelic Science 2027.

Fundraising now

The Social Insights Hub

In partnership with MAPS, we are fundraising to build the Psychedelics Social Insights Hub: a free, open resource with custom polling, audience research, and communication strategies for the psychedelics movement. The first pieces are already live, including an interactive tool where you can explore all of our data. Next we aim to build state-level maps of public opinion so that advocates and campaigns in each state can see state-specific data and strategies for their audiences.

08 · Technical details

How we did it

The basics of the data, the method, and how well the five audiences hold up. Everything else, including every robustness check, is in the technical report.

1,525US adults who answered all nine segmentation questions, surveyed online in November 2023
±3.1point margin of error for all adults, at 95% confidence
0.82entropy: how cleanly people sort into one audience, where 1 is perfectly clean
88%average probability that a respondent belongs to the audience they were assigned to

The data

The XandY Omnibus surveyed 1,527 US adults online from November 17 to 19, 2023, weighted to represent the US adult population. 1,525 of them answered all nine segmentation questions, and they are the people described in this report. Nobody was excluded for how they answered.

The method

A latent class model sorts people by the pattern of their answers to the nine questions. The policy, trust and demographic questions were never used to build the audiences, so the differences on those questions are evidence that the groups are real. We fitted two through seven groups and chose five: the point where the fit stops improving and every group is still large enough to describe.

How well it holds up

People sort cleanly: entropy is 0.82, and the average respondent has an 88% probability of belonging to their assigned audience. Refitting the model on random halves of the sample reproduces the same groups (adjusted Rand index 0.80). Figures for a single audience carry wider margins than the ±3.1 points for all adults, because each audience is a fraction of the sample.

XandY Analytics

Founded by two Yale scientists, XandY is a research and strategy firm that helps the world’s most important ideas build momentum in society. Partnering with organizations we believe in, we build world-class research engines so our clients can locate and move the levers that create lasting social change.

Citation: Goldberg, M. H. & Gustafson, A. (2026). The Psychedelic Five: The audiences shaping America’s psychedelics debate, and how to communicate with each one. XandY. New Haven, CT.

© 2026 XandY.